Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision (v3.7.0) was added to the study record history, and the prior revision (v3.6.6) was removed from the history list. This reflects an update to the record's version history rather than substantive changes to the study data.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history and the previous revision (v3.6.5) was removed from the current history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history shows a new revision entry, 'Revision: v3.6.5', added to replace the previous 'Revision: v3.6.4'. This documents an updated version of the study record.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry (v3.6.4) was added to the study’s record history, replacing the previous revision (v3.6.3). This reflects an updated version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check94 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's history, replacing the previous v3.6.2 entry as part of ongoing record updates. This appears to be administrative maintenance rather than changes to the study design or eligibility.SummaryDifference0.1%

- Check101 days agoChange DetectedAn updated revision entry v3.6.2 has been added to the study record history, and the older entry v3.6.0 has been removed. This reflects an administrative update to the study record's version history rather than changes to the study content or results.SummaryDifference0.1%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.